Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Dec 13 04:00PM ET
4.70
Dollar change
+0.06
Percentage change
1.29
%
Index- P/E- EPS (ttm)-1.14 Insider Own53.78% Shs Outstand18.99M Perf Week-3.49%
Market Cap91.98M Forward P/E- EPS next Y-0.95 Insider Trans0.19% Shs Float8.93M Perf Month-55.95%
Income-19.37M PEG- EPS next Q-0.25 Inst Own5.46% Short Float15.90% Perf Quarter-26.56%
Sales0.00M P/S- EPS this Y29.60% Inst Trans-36.93% Short Ratio8.25 Perf Half Y-30.58%
Book/sh0.58 P/B8.12 EPS next Y5.96% ROA-97.93% Short Interest1.42M Perf Year-44.58%
Cash/sh0.88 P/C5.36 EPS next 5Y- ROE-140.00% 52W Range4.52 - 12.10 Perf YTD-43.65%
Dividend Est.- P/FCF- EPS past 5Y- ROI-176.27% 52W High-61.16% Beta0.21
Dividend TTM- Quick Ratio2.74 Sales past 5Y0.00% Gross Margin- 52W Low3.98% ATR (14)0.60
Dividend Ex-Date- Current Ratio2.74 EPS Y/Y TTM22.97% Oper. Margin- RSI (14)37.53 Volatility6.27% 9.97%
Employees13 Debt/Eq0.00 Sales Y/Y TTM- Profit Margin- Recom1.00 Target Price22.00
Option/ShortNo / Yes LT Debt/Eq0.00 EPS Q/Q34.01% Payout- Rel Volume0.66 Prev Close4.64
Sales Surprise- EPS Surprise4.91% Sales Q/Q- EarningsNov 05 BMO Avg Volume172.09K Price4.70
SMA20-4.83% SMA50-28.36% SMA200-32.24% Trades Volume113,655 Change1.29%
Date Action Analyst Rating Change Price Target Change
Jul-13-22Initiated Ladenburg Thalmann Buy $21
Dec-10-24 08:00AM
08:00AM
Nov-25-24 09:55AM
Nov-15-24 07:45AM
Nov-14-24 02:23PM
07:00AM Loading…
07:00AM
Nov-13-24 08:50AM
Nov-07-24 09:55AM
Nov-05-24 07:00AM
Oct-28-24 08:21AM
Oct-23-24 08:00AM
Oct-07-24 08:00AM
Sep-16-24 07:15AM
Sep-05-24 08:00AM
Aug-30-24 06:52AM
08:00AM Loading…
Aug-29-24 08:00AM
Aug-06-24 08:28AM
May-28-24 06:10AM
May-24-24 09:55AM
May-16-24 08:30AM
May-07-24 09:06PM
01:53PM
08:00AM
Apr-08-24 08:30AM
Apr-02-24 04:30PM
Mar-19-24 08:00AM
Mar-15-24 08:00AM
Mar-14-24 09:00AM
Mar-05-24 11:52PM
08:31AM
08:00AM Loading…
08:00AM
Feb-09-24 08:32AM
08:00AM
Jan-03-24 08:00AM
Dec-18-23 08:00AM
Nov-08-23 08:00AM
Oct-24-23 08:00AM
Oct-16-23 09:35AM
Sep-25-23 07:30PM
Sep-21-23 08:00AM
Sep-12-23 08:00AM
Sep-06-23 08:00AM
Sep-01-23 08:00AM
Aug-17-23 08:00AM
Aug-11-23 07:01AM
Aug-10-23 06:24AM
Aug-09-23 08:00AM
06:26AM
Aug-08-23 06:28AM
Aug-07-23 06:35AM
Aug-04-23 07:14AM
Aug-03-23 07:15AM
Aug-02-23 07:52AM
Aug-01-23 06:51AM
06:51AM
Jul-31-23 06:44AM
Jul-28-23 07:58AM
07:58AM
Jul-27-23 07:10AM
Jul-26-23 01:12PM
Jul-25-23 07:16AM
07:16AM
Jul-24-23 07:12AM
Jul-21-23 07:23AM
07:23AM
Jul-20-23 06:55AM
06:55AM
Jul-19-23 07:10AM
07:10AM
Jul-18-23 06:53AM
Jul-17-23 07:10AM
Jul-14-23 06:50AM
06:50AM
Jul-13-23 07:02AM
07:02AM
Jul-12-23 07:22AM
Jul-11-23 06:08AM
06:08AM
Jul-10-23 06:56AM
06:56AM
Jul-05-23 06:46AM
Jul-03-23 06:50AM
Jun-30-23 06:52AM
Jun-29-23 06:49AM
Jun-28-23 07:13AM
06:58AM
Jun-27-23 06:46AM
06:46AM
Jun-26-23 06:41AM
Jun-21-23 07:20AM
Jun-20-23 08:00AM
06:35AM
Jun-18-23 08:03AM
Jun-05-23 08:50AM
Jun-01-23 04:48AM
May-31-23 06:22AM
May-19-23 08:50AM
May-15-23 09:55AM
08:00AM
May-10-23 08:00AM
Nuvectis Pharma, Inc. is a preclinical stage biopharmaceutical company. It focuses on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its product pipeline includes NXP800 and NXP900. The company was founded by Ron Bentsur, Enrique Poradosu and Shay Shemesh on July 27, 2020 and is headquartered in Fort Lee, NJ.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Poradosu EnriqueChief Science & Business OffNov 19 '24Buy4.992,0009,9801,506,319Nov 20 08:30 AM
BENTSUR RONChairman & CEONov 15 '24Buy4.9220,00098,4003,266,424Nov 18 08:30 AM
Carson Michael J.Vice President, FinanceNov 07 '24Sale8.162,75522,47887,918Nov 08 03:59 PM
BENTSUR RONChairman & CEOMay 14 '24Buy6.741,94013,0763,246,424May 15 09:16 AM
BENTSUR RONChairman & CEOMay 10 '24Buy6.402,00012,8003,244,484May 13 08:51 AM
Poradosu EnriqueChief Science & Business OffMay 10 '24Buy6.295003,1451,504,319May 13 08:49 AM
Shemesh ShayChief Dev. & Ops. OfficerMay 10 '24Buy6.321,1137,0341,493,068May 13 08:47 AM
BENTSUR RONChairman & CEOMar 18 '24Buy10.295,00051,4503,242,484Mar 19 08:00 AM